Radiogenomic biomarkers for immunotherapy in glioblastoma: A systematic review of magnetic resonance imaging studies

Prajwal Ghimire, Ben Kinnersley, Golestan Karami, Prabhu Arumugam, Richard Houlston, Keyoumars Ashkan, Marc Modat, Thomas C Booth

Open source

DOI
10.1093/noajnl/vdae055
Published
2024-01-01
Container
Neuro-Oncology Advances
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/noajnl/vdae055,
  title = {Radiogenomic biomarkers for immunotherapy in glioblastoma: A systematic review of magnetic resonance imaging studies},
  author = {Prajwal Ghimire and Ben Kinnersley and Golestan Karami and Prabhu Arumugam and Richard Houlston and Keyoumars Ashkan and Marc Modat and Thomas C Booth},
  year = {2024},
  journal = {Neuro-Oncology Advances},
  doi = {10.1093/noajnl/vdae055},
  url = {https://doi.org/10.1093/noajnl/vdae055}
}

RIS

TY  - JOUR
TI  - Radiogenomic biomarkers for immunotherapy in glioblastoma: A systematic review of magnetic resonance imaging studies
AU  - Prajwal Ghimire
AU  - Ben Kinnersley
AU  - Golestan Karami
AU  - Prabhu Arumugam
AU  - Richard Houlston
AU  - Keyoumars Ashkan
AU  - Marc Modat
AU  - Thomas C Booth
PY  - 2024
JO  - Neuro-Oncology Advances
DO  - 10.1093/noajnl/vdae055
UR  - https://doi.org/10.1093/noajnl/vdae055
ER  - 

APA

Ghimire, P., Kinnersley, B., Karami, G., Arumugam, P., Houlston, R., Ashkan, K., Modat, M., & Booth, T. C. (2024). Radiogenomic biomarkers for immunotherapy in glioblastoma: A systematic review of magnetic resonance imaging studies. Neuro-Oncology Advances. https://doi.org/10.1093/noajnl/vdae055

Source records